The share price is and has been manipulated for a number of...

The share price is and has been manipulated for a number of weeks/months.

And I believe it's because of the escrow expiry of Swinnerton's remaining shares.

I've stated before, my hunch is Regal wants it and they will use VWAP as their bid.

Management: You can have 15.5M for xx cents per share.

Regal: Pfft. Why would we pay xx cents when the share price is 3x cents. Our bid is 10% below VWAP.

For anyone buying into the higher sells, they would only see the share price sold down in low volume, as we've been seeing day in, day out for the last few weeks. Regal are in control and keeping this range bound which is just tightening the coil. The longer the accumulation, the bigger the bounce.

Even if the recent programs aren't set to earn millions, I'm curious why Management aren't even choosing to publish them. Barring mandatory reporting announcements, the last news item was published in November.

https://www.digitalhealthcrc.com/news-afib-recruits-patients/

https://healthengine.com.au/press/2...m-for-pharmacies-with-medadvisor-integration/

If my thoughts above are correct and they can demonstrate ~$13M for the March quarter, then I suspect this will run hard in April and May. Follow that up in Q4 with some NPA contracts and large US Health Programs under Adheris, then in FY22 they can aim for $100M revenue.

https://www.npa.co.uk/businesspartners/medadvisor/

Even if current revenue targets are met at $56M annually, there is no way this company is only worth $125M.

We wait..........